New antibiotics for selective treatment of gastrointestinal infection caused byClostridium difficile
- 11 August 2010
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 20 (10) , 1389-1399
Abstract
(2010). New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile. Expert Opinion on Therapeutic Patents: Vol. 20, No. 10, pp. 1389-1399. doi: 10.1517/13543776.2010.511177Keywords
This publication has 27 references indexed in Scilit:
- Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infectionAnaerobe, 2009
- Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomesJournal of Infection, 2009
- What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?Journal of Antimicrobial Chemotherapy, 2008
- In Vitro Activity of OPT-80 Tested against Clinical Isolates of Toxin-Producing Clostridium difficileAntimicrobial Agents and Chemotherapy, 2008
- Emergence of reduced susceptibility to metronidazole in Clostridium difficileJournal of Antimicrobial Chemotherapy, 2008
- A case-control study of community-associated Clostridium difficile infectionJournal of Antimicrobial Chemotherapy, 2008
- In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004Antimicrobial Agents and Chemotherapy, 2007
- In Vitro Activities of OPT-80 and Comparator Drugs against Intestinal BacteriaAntimicrobial Agents and Chemotherapy, 2004
- Activity of OPT-80, a Novel Macrocycle, Compared with Those of Eight Other Agents against Selected Anaerobic SpeciesAntimicrobial Agents and Chemotherapy, 2004
- In Vitro Activity of OPT-80 against Clostridium difficileAntimicrobial Agents and Chemotherapy, 2004